US House Democratic Women's Caucus press health secretary on estrogen patch shortages
Val Hoyle called for a response to the estrogen-patch shortage and said the issue was not receiving enough attention.

SOURCE CHECK
TAP FOR WHYReuters is a major international wire service with established reporting and editorial standards. This story identifies its reporters and describes a letter Reuters reviewed, while also attributing claims and including the FDA’s account of its response.
- Source type — A major wire service with a strong record of original reporting.
- Editorial standards — Reuters identifies its Trust Principles and an editing process.
- Transparency — The story says it reviewed a copy of the letter and attributes reported claims.
- Author attribution — Reporting and editing credits are provided.
The report identifies the letter’s requests, cites Reuters’ reporting on the shortage, and includes the FDA’s statement that it was working with manufacturers. It does not include a response from the secretary or acting commissioner to the letter’s specific requests.
HOW WE SCORE ↗The story includes the lawmakers’ concerns and the FDA’s earlier statement about increasing supply, but does not provide a direct response to the letter or the agency’s account of the specific bottlenecks.
- Counterarguments presented — The FDA’s earlier statement is included, but no direct response to the caucus’s requests is reported.
- Source diversity — The story draws on a reviewed letter, a lawmaker’s comments, and an FDA statement.
- Omitted context — The article gives limited detail about the causes of the shortage or the agency’s specific steps.
The report uses neutral language and attributes the lawmakers’ concerns and the FDA’s response. Its framing centers on the supply disruption and the caucus’s request without apparent partisan advocacy.
- Language tone — Descriptive language, with lawmakers’ assessments attributed to them.
- Source selection — Includes the caucus’s account and the FDA’s statement about its work with manufacturers.
- Framing — Focuses on the shortage and the request for agency information rather than partisan conflict.
The House Democratic Women’s Caucus asked Health Secretary Robert F. Kennedy Jr. and the FDA’s acting commissioner for information and a plan to address estrogen-patch shortages. Representative Val Hoyle said the issue was not getting enough attention and warned lawmakers would find a way to press for a response.
The 96-member Democratic Women’s Caucus sent a letter seeking details on the prolonged estrogen-patch supply disruption, a timeline for stabilizing supply, and consideration of adding the patches to the FDA’s shortage list. The letter also requested information on supply-chain bottlenecks, affected brands and dosages, and whether additional manufacturers might help. Reuters reported that some women have had to reduce or switch dosages, brands, or types of therapy.
Community verdict
15 VOTESPeople in this story
SWIPE →Representative urging health officials to address estrogen-patch shortages
Representative who previously wrote to the FDA about the shortage
Health secretary who received the caucus's request
Discussion · 0
Loading comments…


